Tsumura & Co
TSE:4540
Intrinsic Value
Tsumura & Co. engages in the manufacture and sale of pharmaceutical products. [ Read More ]
The intrinsic value of one Tsumura & Co stock under the Base Case scenario is 4 673.78 JPY. Compared to the current market price of 3 850 JPY, Tsumura & Co is Undervalued by 18%.
Valuation Backtest
Tsumura & Co
Run backtest to discover the historical profit from buying and selling Tsumura & Co stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Tsumura & Co
Current Assets | 278.7B |
Cash & Short-Term Investments | 80.5B |
Receivables | 69.6B |
Other Current Assets | 128.6B |
Non-Current Assets | 139.5B |
Long-Term Investments | 14.3B |
PP&E | 99.3B |
Intangibles | 16.8B |
Other Non-Current Assets | 9.2B |
Current Liabilities | 57.6B |
Accounts Payable | 13.6B |
Short-Term Debt | 10.3B |
Other Current Liabilities | 33.7B |
Non-Current Liabilities | 89.6B |
Long-Term Debt | 54.4B |
Other Non-Current Liabilities | 35.3B |
Earnings Waterfall
Tsumura & Co
Revenue
|
148.8B
JPY
|
Cost of Revenue
|
-78B
JPY
|
Gross Profit
|
70.8B
JPY
|
Operating Expenses
|
-48.4B
JPY
|
Operating Income
|
22.3B
JPY
|
Other Expenses
|
-5.6B
JPY
|
Net Income
|
16.8B
JPY
|
Free Cash Flow Analysis
Tsumura & Co
What is Free Cash Flow?
Profitability Score
Profitability Due Diligence
Tsumura & Co's profitability score is 53/100. The higher the profitability score, the more profitable the company is.
Score
Tsumura & Co's profitability score is 53/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Tsumura & Co's solvency score is 80/100. The higher the solvency score, the more solvent the company is.
Score
Tsumura & Co's solvency score is 80/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Tsumura & Co
According to Wall Street analysts, the average 1-year price target for Tsumura & Co is 4 889.2 JPY with a low forecast of 4 747 JPY and a high forecast of 5 145 JPY.
Shareholder Return
Price
Tsumura & Co
Average Annual Return | -2% |
Standard Deviation of Annual Returns | 11.32% |
Max Drawdown | -33% |
Market Capitalization | 292.3B JPY |
Shares Outstanding | 76 391 400 |
Percentage of Shares Shorted |
N/A
|
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Tsumura & Co. engages in the manufacture and sale of pharmaceutical products. The company is headquartered in Minato-Ku, Tokyo-To and currently employs 3,830 full-time employees. Through its subsidiaries, the Company is also engaged in the procurement, sorting and processing of crude drugs, the manufacture and sale of Chinese herbal extract powders and drug substances, the operation of dispensing pharmacies and the provision of logistics services, as well as the development of pharmaceuticals.
Contact
IPO
Employees
Officers
The intrinsic value of one Tsumura & Co stock under the Base Case scenario is 4 673.78 JPY.
Compared to the current market price of 3 850 JPY, Tsumura & Co is Undervalued by 18%.